Physician profile
Jana Sanders
NPI 1568530160
$4,229.46
in general payments reported to CMS, 2019-2025
31 companies · $1,583 in 2025
The $1,583 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $128 · 2022: $21.77 · 2023: $902 · 2024: $1,595 · 2025: $1,583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,959 · Education: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,958.79 |
| Education | $120.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $797.92 | 2023-2025 | Breztri, Fasenra, Airsupra |
| Takeda Pharmaceuticals U.S.A., INC. | $589.64 | 2021-2025 | Glassia, Trintellix |
| Glaxosmithkline, LLC. | $421.45 | 2021-2025 | Trelegy Ellipta, Nucala, Shingrix |
| Otsuka America Pharmaceutical, INC. | $293.73 | 2021-2025 | Rexulti |
| Insmed, INC. | $246.64 | 2023-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $170.58 | 2024-2025 | Dupixent |
| Abbvie INC. | $156.13 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $148.68 | 2025 | Austedo Xr |
| United Therapeutics Corporation | $141.01 | 2023-2025 | Tyvaso, Tyvaso |
| Amgen INC. | $126.14 | 2024-2025 | Tezspire, Otezla, Repatha |
| Mylan Specialty L.P. | $121.26 | 2023-2024 | Yupelri |
| Alkermes, INC. | $104.68 | 2021-2025 | Aristada, Lybalvi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.50 | 2024-2025 | Jascayd |
| Axsome Therapeutics, INC. | $95.67 | 2024-2025 | Sunosi, Auvelity |
| Genzyme Corporation | $92.39 | 2024-2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $91.16 | 2025 | Yupelri |
| Grifols USA, LLC | $76.81 | 2023-2024 | Prolastin-C Liquid |
| Neurocrine Biosciences, INC. | $76.26 | 2024-2025 | Ingrezza |
| Inspire Medical Systems, INC. | $66.02 | 2023 | Inspire |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $51.41 | 2025 | Caplyta |
| Paratek Pharmaceuticals, INC. | $40.76 | 2023-2024 | Nuzyra |
| Corcept Therapeutics | $34.77 | 2024 | Korlym |
| Almatica Pharma LLC | $31.72 | 2021-2025 | Loreev Xr |
| E.R. Squibb & Sons, L.L.C. | $26.81 | 2025 | Cobenfy |
| Baxter Healthcare | $21.14 | 2023 | Hillrom - Life 2000 Ventilation System |
| Lilly USA, LLC | $19.88 | 2025 | Zepbound |
| Harmony Biosciences LLC | $19.30 | 2024 | |
| Inogen, INC. | $19.05 | 2024 | |
| Novo Nordisk INC | $15.96 | 2025 | Ozempic |
| Tactile Systems Technology INC | $14.51 | 2024 | Flexitouch Plus, Entre Plus |
| Electromed, INC. | $14.48 | 2025 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jana Sanders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.